The Asia Pacific human leukocyte antigen (HLA) testing market is expected to grow from US$ 154.35 million in 2022 to US$ 243.18 million by 2028; it is estimated to grow at a CAGR of 7.9% from 2022 to 2028.

Living organ donations and deceased organ donations (DCD) are the two types of organ donations. The demand for both types of organ donations is rising day by day due to the elevating cases of chronic illnesses. Additionally, as per the Ministry of Health and Family Welfare (MoHFW) of the Government of India, annually, 500,000 people die because of the non-availability of organs; 200,000 people die due to liver disorders; and 50,000 people die because of heart disease. Moreover, 150,000 people await a kidney transplant, but only 5,000 get kidneys for transplantation. These numbers indicate the need for organ donors, which is much greater than the actual number of donations. Similar scenarios have been found in other nations of the world. To balance the demand and supply of organs, governments of several countries have implemented various strategies to promote organ donation. Such initiatives by governments are creating opportunities for HLA testing market players, as the rise in organ donations and transplantation procedures is likely to propel the demand for HLA testing.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.

Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Segmentation

The Asia Pacific human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Asia Pacific human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the Asia Pacific human leukocyte antigen (HLA) testing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific.

Asia Pacific Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned

THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina, Inc.; Bio-Rad Laboratories, Inc.; TBG Diagnostics Limited; F. HOFFMANN-LA ROCHE LTD.; Takara Bio Inc.; and Luminex Corporation are among the major companies operating in the Asia Pacific human leukocyte antigen (HLA) testing market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – By Product and Services
1.3.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – By Technology
1.3.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – By End User
1.3.4 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – By Country
2. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Analysis
6.1 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
7. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services
7.1 Overview
7.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.2.1 Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology
8.1 Overview
8.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.2.1 Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
8.2.1.1 Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User
9.1 Overview
9.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.2.1 Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Country
10.1 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3 Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
10.1.3.1 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.1.3.1.1 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.2 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.1.3.1.3 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.1.3.1.3.1 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.1.4 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.3.2 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.1 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.2 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.1.3.2.3 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.1.3.2.3.1 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.2.4 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.3.3 India Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.1.3.3.1 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.2 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.1.3.3.3 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.1.3.3.3.1 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.3.4 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.3.4 South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.1.3.4.1 South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.4.2 South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.1.3.4.3 South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.1.3.4.3.1 South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.4.4 South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.3.5 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.5.1 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.5.2 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.1.3.5.3 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.1.3.5.3.1 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.5.4 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.3.6 Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3.6.1 Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.6.2 Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.1.3.6.3 Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.1.3.6.3.1 Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.6.4 Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
11. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 CareDx
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 TBG Diagnostics Limited
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 F. HOFFMANN-LA ROCHE LTD.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Luminex Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 2. Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
Table 3. Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 4. Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 5. China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 6. China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 7. China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 8. China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 9. Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 10. Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
Table 11. Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 12. Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 13. India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 14. India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 15. India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 16. India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 17. South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 18. South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 19. South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 20. South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 21. Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 22. Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 23. Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 24. Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 26. Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 27. Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 28. Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 29. Organic Developments in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market
Table 30. Inorganic Developments in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market
Table 31. Glossary of Terms, Asia Pacific Human Leukocyte Antigen (HLA) Testing Market

LIST OF FIGURES

Figure 1. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Segmentation
Figure 2. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Overview
Figure 3. Reagents And Consumables Held Largest Share of Product Segment in Asia Pacific Human Leukocyte Antigen (HLA) Testing Market
Figure 4. Asia Pacific Region is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific: PEST Analysis
Figure 6. Experts’ Opinion
Figure 7. HLA Testing Market: Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
Figure 10. Reagents and Consumables: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 11. Instruments: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 12. Software and Services : Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
Figure 14. Molecular Assay Technologies: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. PCR-Based Molecular Assays: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Sequencing-Based Molecular Assays: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Non-Molecular Assay Technologies: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)
Figure 20. Independent Reference Laboratories: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hospital & Transplant Centers: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)
Figure 24. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
Figure 26. China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Japan Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 29. South Korea: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 30. Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 31. Rest of Asia Pacific: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast To 2028 (US$ Million)
Figure 32. Growth Strategies in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market (%)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Human Leukocyte Antigen (HLA) Testing Market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies – Asia Pacific Human Leukocyte Antigen (HLA) Testing Market

● THERMO FISHER SCIENTIFIC INC.                            
● CareDx                                                                     
● QIAGEN                                                                                              
● Illumina, Inc.                                                                     
● Bio-Rad Laboratories, Inc.                                           
● TBG Diagnostics Limited                                                               
● F. HOFFMANN-LA ROCHE LTD.                                  
● Takara Bio Inc.                                                                  
● Luminex Corporation